N-(4-methyl-3-(4-(pyrazolo[1,5-a]pyrimidin-6-yl)-1H-pyrazol-1-yl)phenyl)-4-(morpholinomethyl)benzamide

ID: ALA4779313

PubChem CID: 162662805

Max Phase: Preclinical

Molecular Formula: C28H27N7O2

Molecular Weight: 493.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCOCC3)cc2)cc1-n1cc(-c2cnc3ccnn3c2)cn1

Standard InChI:  InChI=1S/C28H27N7O2/c1-20-2-7-25(32-28(36)22-5-3-21(4-6-22)17-33-10-12-37-13-11-33)14-26(20)34-18-24(16-31-34)23-15-29-27-8-9-30-35(27)19-23/h2-9,14-16,18-19H,10-13,17H2,1H3,(H,32,36)

Standard InChI Key:  IMYGEMTZBOEKDJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
    7.2460   -8.9024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2449   -9.7219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9529  -10.1309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6626   -9.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6597   -8.8988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9511   -8.4935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5382   -8.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3709  -10.1289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0780   -9.7192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7863  -10.1267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0767   -8.9020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7830  -10.9424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4905  -11.3498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1985  -10.9400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1946  -10.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4865   -9.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5368  -10.1300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7951   -9.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2478  -10.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6559  -11.1111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4553  -10.9417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4285  -10.3965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0258   -9.6819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2101   -9.6735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0156  -11.1026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1937  -11.0924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7914  -10.3737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9834  -10.5342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8864  -11.3522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6344  -11.6971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9074  -11.3465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9098  -12.1637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2001  -12.5690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2005  -13.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9075  -13.7930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6159  -13.3836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6171  -12.5638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
 19 22  1  0
 22 23  1  0
 22 25  2  0
 23 24  2  0
 24 27  1  0
 26 25  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 14 31  1  0
 31 32  1  0
 32 33  1  0
 32 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4779313

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 493.57Molecular Weight (Monoisotopic): 493.2226AlogP: 3.97#Rotatable Bonds: 6
Polar Surface Area: 89.58Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.60CX LogP: 3.71CX LogD: 3.65
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -2.09

References

1. Hu L,Cao T,Lv Y,Ding Y,Yang L,Zhang Q,Guo M.  (2016)  Design, synthesis, and biological activity of 4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl-phenylbenzamide derivatives as BCR-ABL kinase inhibitors.,  26  (23.0): [PMID:28029512] [10.1016/j.bmcl.2016.10.007]

Source